Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins-Reference-Cited by-同舟云学术

Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins

Published:2017-07-11 Issue:1 Volume:17 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Myers Jennifer S.,Vallega Karin A.,White Jason,Yu Kaixian,Yates Clayton C.,Sang Qing-Xiang Amy

Funder

National Center on Minority Health and Health Disparities

National Cancer Institute

Florida State University

U.S. Department of Defense

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3462-7.pdf

Reference57 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.

2. Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst. 2000;92:2009–17.

3. Wells TS, Bukowinski AT, Smith TC, Smith B, Dennis LK, Chu LK, et al. Racial differences in prostate cancer risk remain among US servicemen with equal access to care. Prostate. 2010;70:727–34.

4. Karami S, Young HA, Henson DE. Earlier age at diagnosis: another dimension in cancer disparity? Cancer Detect Prev. 2007;31:29–34.

5. Chornokur G, Dalton K, Borysova ME, Kumar NB. Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate. 2011;71:985–97.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Scaled Proteomic Discovery Study for Prostate Cancer Diagnostic Markers Using ProteographTM and Trapped Ion Mobility Mass Spectrometry;International Journal of Molecular Sciences;2024-07-23

2. Characterisation of cell lines derived from prostate cancer patients with localised disease;Prostate Cancer and Prostatic Diseases;2023-06-01

3. Translational Efforts in Precision Medicine to Address Disparities;Cancer Health Disparities;2023

4. Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry;Nature Reviews Urology;2021-08-27

5. The mechanobiome: a goldmine for cancer therapeutics;American Journal of Physiology-Cell Physiology;2021-03-01